Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Critical Care Medicine|December 24, 2005
Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndromeAnne Hilgendorff, Martin Doerner, Daniel Rawer, et al.
Toxicology and Applied Pharmacology|March 5, 2004
Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosisReinhold Schmidt, Clemens Ruppert, Philipp Markart, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2022
WNT/RYK signaling functions as an antiinflammatory modulator in the lung mesenchymeHyun-Taek Kim, Paolo Panza, Khrievono Kikhi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 5, 2025
Reduced surfactant protein B levels impede unfolding of the pulmonary blood-gas barrier during inspiration in miceHannia M Buchholz, Franziska Roeder, Dirk Wedekind, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2010
Recombinant surfactant protein C-based surfactant for patients with severe direct lung injuryRoger G Spragg, Friedemann J H Taut, James F Lewis, et al.
Antioxidants & Redox Signaling|September 12, 2008
Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseasesPhilipp Markart, Thomas Luboeinski, Martina Korfei, et al.
Thrombosis and Haemostasis|January 10, 2009
Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinaseClemens Ruppert, Poornima Mahavadi, Malgorzata Wygrecka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signalingGani Oruqaj, Srikanth Karnati, Vijith Vijayan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 29, 2017
Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin modelLilian Steffen, Clemens Ruppert, Heinz-Gerd Hoymann, et al.
Thorax|February 9, 2007
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipidsPhilipp Markart, Clemens Ruppert, Malgorzata Wygrecka, et al.
Pageof 11